Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Tiny Tools Help Advance Medical Discoveries

Published: Tuesday, January 08, 2013
Last Updated: Tuesday, January 08, 2013
Bookmark and Share
MIT researchers are designing tools to analyze cells at the microscale.

To understand the progression of complex diseases such as cancer, scientists have had to tease out the interactions between cells at progressively finer scales — from the behavior of a single tumor cell in the body on down to the activity of that cell’s inner machinery.

To foster such discoveries, mechanical engineers at MIT are designing tools to image and analyze cellular dynamics at the micro- and nanoscale. Such tools, including microfluidics, membrane technology and metamaterials, may help scientists better characterize and develop therapies for cancer and other complex diseases.

New medical discoveries depend on engineering advances in real-time, multifunctional imaging and quantitative analysis, says Nicholas Fang, an associate professor of mechanical engineering.

“What we’ve learned so far is more or less the architecture of cells, and the next layer is the dynamics of cells,” says Fang, who is developing optical sensors to illuminate individual components within a cell. “Cells operate like a city, or a metropolitan area: You have traffic, flow of information, and logistics of materials, and responses related to different events. Medicine requires new modes of seeing these events with better precision in time and space.”

Materials beyond nature

Fang is developing new imaging tools from metamaterials — materials engineered to exhibit properties not normally found in nature. Such materials may be designed as “superlenses” that bend and refract light to image extremely small objects. For example, Fang says that today’s best imaging tools can capture signaling between individual neurons, which may appear as a fuzzy “plume” of neurotransmitters. A superlens, in contrast, would let scientists see individual neurotransmitter molecules at the scale of a few nanometers. Such acuity, he says, would allow scientists to identify certain chemical transmitters that are directly related to particular diseases.

Metamaterials may also help scientists manipulate cells at the microscale. Fang is exploring the use of metamaterials as optical antennae to improve a technique known as optogenetics. This technique, developed in 2005 (and pioneered by MIT’s Ed Boyden, the Benesse Career Development Associate Professor of Research in Education), involves genetically engineering proteins to respond to light. Using various colors of light, scientists may control the activity or expression of such proteins to study the progression of disease. However, researchers have found that the technique requires a large amount of light to prompt a response, risking overheating or damaging the proteins of interest.

To solve this problem, Fang and his colleagues are looking to metamaterials to design tiny optical receivers, similar to radio antennae. Such receivers would attach to a given protein, boosting its receptivity to light, and thereby requiring less light to activate the protein. The project is in its initial stages; Fang says his group is now seeking materials that are compatible with proteins and other biological tissues.

Sorting cells

MIT researchers are also developing tools to sort individual cells — part of an effort to provide simple, cost-effective diagnostic tools for certain diseases. Rohit Karnik, an associate professor of mechanical engineering, is approaching cell sorting from a variety of directions. His lab is fabricating microfluidic, or “lab-on-a-chip,” devices — chips as small as a dime that efficiently sort cells, separating out those of interest from a sample of blood or biological fluid.

Karnik’s group employs nanofabrication techniques to etch tiny, precisely patterned channels into small squares of polymer. The arrangement of the channels directs fluid, capturing cells of interest via “cell rolling,” a phenomenon by which cells roll to one side of a channel, attracted by a wall’s surface coating. The device is a relatively simple, passive cell-sorter that Karnik says may efficiently sort out material such as white blood cells — cells that may quickly be counted to identify conditions such as sepsis and inflammation.  

Karnik is also developing small membranes punctured with microscopic pores. Each pore is a few nanometers wide, small enough to let individual DNA molecules through. By passing an electric current through the nanopore, the researchers can measure certain characteristics of a DNA molecule, such as its size and the presence of any additional proteins bound to it.

Such membrane technology may drastically simplify the process of sizing DNA molecules and mapping DNA modifications, which are critical for understanding gene regulation and the dynamics of cellular machinery — now a lengthy process that involves expensive bench-top instruments. Instead, Karnik says, nanopore membranes may be a faster, cheaper alternative that could work with single DNA molecules with no loss of information from DNA-amplification steps.

Cancer in a chip

Researchers are investigating microfluidics not only as a means to sort cells, but as a way of replicating whole biological environments at the microscale.

“We use microfluidics to develop more realistic models of organs and human physiology so that we can look at, for example, how a tumor cell interacts with other cells in the local environment,” says Roger Kamm, the Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering.

Kamm and his colleagues have developed a microfluidic chip that contains tiny channels and reservoirs, in which they can seed various cell types. The group is using the device to study how cancer spreads through the body. Cancer becomes metastatic when tumor cells break off from a primary tumor and cross through a blood vessel wall and into the bloodstream. Kamm is using the group’s microfluidic designs to mimic the metastatic process and identify agents to prevent it.

To replicate the lining of a blood vessel, Kamm seeds one channel in the chip with endothelial cells. In a neighboring channel, he injects a gel, mimicking the body’s extracellular matrix. The group can introduce tumor cells into the gel, along with other chemical agents. In the controlled setup, they can monitor the behavior of tumor cells, and the conditions in which the cells penetrate the endothelial lining, in order to enter a blood vessel.

“This allows us to put cells in close proximity so they can signal with each other in a more realistic fashion,” Kamm says.

Compared with conventional cancer-screening techniques, the microfluidic technique more closely resembles natural processes in the body, Kamm says. For example, pharmaceutical companies tend to test potential drugs in large batches, injecting a drug into tiny, isolated wells containing tumor cells. That works well to test for drugs that kill the tumor, but not so well for identifying drugs that can prevent metastatic disease.

“What we’re finding is that cells behave completely differently when you have a realistic environment, with cells communicating with different cell types, and when a cell is in a three-dimensional matrix, as opposed to when you have a single cell type inside a well on a two-dimensional, rigid surface,” Kamm says. “High-throughput systems probably miss a lot of potentially good drugs, and they also identify drugs that fail at subsequent stages of testing.”

Karnik, who has collaborated with Kamm on a few lab-on-a-chip designs, sees such devices and other engineering tools as a key connection in pushing medical discoveries, and effective therapies, forward.

“A clinician might say, ‘I need to know whether the patient has this disease or that disease,’ and the biologist would say, ‘Oh, in order to do that, you need to measure molecules A, B and C,’ and it’s up to the engineers to figure out how to do it,” Karnik says. “That’s our key role, bridging in between.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Using Ultrasound to Improve Drug Delivery
New approach could aid in treatment of inflammatory bowel disease.
Friday, October 23, 2015
Drug-Resistance Mechanism in Tumor Cells Unravelled
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Friday, October 23, 2015
Biologists Find Unexpected Role for Amyloid-Forming Protein
Yeast protein could offer clues to how Alzheimer’s plaques form in the brain.
Monday, September 28, 2015
Viruses Join Fight Against Harmful Bacteria
Engineered viruses could combat human disease and improve food safety.
Friday, September 25, 2015
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Tuesday, September 22, 2015
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Friday, August 21, 2015
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Friday, July 31, 2015
Firms “Under-invest” in Long-Term Cancer Research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Thursday, July 30, 2015
Nanoparticles Can Clean Up Environmental Pollutants
Researchers have found that nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
Thursday, July 23, 2015
Tough biogel structures produced by 3-D printing
Researchers have developed a new way of making tough — but soft and wet — bio-compatible materials, called “hydrogels,” into complex and intricately patterned shapes.
Wednesday, June 03, 2015
Diagnosing Cancer with Help from Bacteria
Engineered probiotics can detect tumors in the liver.
Friday, May 29, 2015
Master Gene Regulator Could Be New Target For Schizophrenia Treatment
Researchers at MIT’s Picower Institute for Learning and Memory have identified a master genetic regulator that could account for faulty brain functions that contribute to schizophrenia.
Wednesday, May 27, 2015
Designing Better Medical Implants
A team of MIT researchers have discovered a novel method for reducing the typical immune system rejection response when implanting biomedical devices into the body.
Wednesday, May 20, 2015
Brain Tumor Weakness Identified
Discovery could offer a new target for treatment of glioblastoma.
Thursday, April 09, 2015
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Wednesday, March 04, 2015
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos